Pharmaceuticals
Drug Stocks Often Trade in a Pack, but Not Now. Here Are Leaders and Laggards
Although pharmaceutical companies as a group are keeping pace with the broader market, there is considerable divergence in individual names.
This Pharma Is Starting to Recover Nicely
Here's a trade idea for Aurinia Pharmaceuticals.
It's Time to Reevaluate Moderna's Charts
Here's what I think we'll see up ahead.
Bearish Bets: 3 Downgraded Stocks You Should Consider Shorting This Week
These names are displaying both quantitative and technical deterioration.
CVS Health's Charts Are Pretty Sickly
The stock has been in a weak trend for more than a year.
Can Pfizer's Charts and Fundamentals Get on the Same Page?
The pharmaceutical giant gained an analyst's buy recommendation but its technical signals are lackluster at best.
Vertex Appears a Bit Under the Weather Ahead of Earnings
The charts give a reading of weakness ahead for this pharma name.
Here's How to Trade Bristol-Myers Squibb After Earnings
If you're a long-term BMY bull, here's what the charts suggest.
Amgen Is Casting a Bearish Technical Hue in Advance of Earnings
The biotech giant's charts have displayed weakness of late as it prepares to report fourth-quarter results.
With Pfizer Firmly in Value Territory, Here's What Investors Are Missing
The stock is already down about 15% in 2023 as the pharmaceutical giant gets set to report earnings.